Bioharvest Sciences Inc.
BHST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001723464
No open-market purchases or sales by Bioharvest Sciences Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $4.80M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −1 vs. previous quarter
- 19
- 13F valueReported value at the end of Q2 2026
- $4.80M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding BHST, Q2 2026
No superinvestor reported holding BHST at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Bioharvest Sciences Inc. insiders from Form 4, newest first.
No open-market purchases or sales by Bioharvest Sciences Inc. insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Bioharvest Sciences Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Alyeska Investment Group, L.P. | 581,441 | $1.66M | 0.00% | −175,623−23.2% | Reduced |
| Thompson Siegel & Walmsley LLC | 364,008 | $1.04M | 0.02% | −22,751−5.9% | Reduced |
| Evercore Wealth Management, LLC | 216,343 | $618.7K | 0.01% | +76,873+55.1% | Added |
| True North Advisors, LLC | 187,318 | $535.7K | 0.05% | +19,305+11.5% | Added |
| Magnus Financial Group LLC | 90,000 | $257.4K | 0.02% | +35,000+63.6% | Added |
| Susquehanna International Group, LLP | 63,658 | $179.5K | 0.00% | +47,264+288.3% | Added |
| Silverberg Bernstein Capital Management LLC | 57,723 | $162.8K | 0.06% | +31,624+121.2% | Added |
| King Luther Capital Management Corp | 40,000 | $114.4K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 23,827 | $65.5K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 20,652 | $58.2K | 0.00% | +5,899+40.0% | Added |